Projects per year
Personal profile
Personal profile
Dr. Andrew Farach is an assistant professor in the Department of Radiation Oncology at Houston Methodist Hospital. His interest and special procedures are in breast cancer, brain cancer, gynecologic cancer, lung cancer, hepatobiliary cancer, gastrointestinal cancer, lymphoma, brachytherapy, stereotactic radiation/surgery. Dr. Farach earned his medical degree from Thomas Jefferson University, Jefferson Medical College in Philadelphia. He completed his internship at the University of Texas Health Science Center and his radiation oncology residency training at Baylor College of Medicine. He became Director of Brachytherapy in the Department of Radiation Oncology at Houston Methodist in 2018. Dr. Farach is active in ASTRO (American Society of Therapeutic Radiology and Oncology), ACR (American College of Radiology), and the Texas Radiological Society (TRS). Dr. Farach has published peer-reviewed articles on topics such as SBRT outcomes in lung cancer, radiation and immunotherapy for breast cancer, and liver regeneration after SBRT. He plays an important role in cancer patient care, clinical research and the education of residents and students.
Research Area Keywords
- Imaging & Radiology
- Cancer
- Clinical Translation & Trials
- Clinical Care
Fingerprint
Dive into the research topics where Andrew M. Farach is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R., Chen, S., Esnaola, N. F., Farach, A. M., Teh, B. S. & Zhang, J.
1/20/22 → …
Project: Clinical Trial
-
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer (NRG-GY006)
Zaid, T., Alaniz, A., Butler, E. B., Farach, A. M., Haque, W. M., Kamat, A. A., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M. & Suri, A.
2/22/19 → …
Project: Clinical Trial
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Adjuvant Chemotherapy in High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy (RTOG 0724/GOG-0724 )
Kamat, A. A., Butler, E. B., Farach, A. M., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M., Suri, A. & Zaid, T.
6/3/11 → …
Project: Clinical Trial
-
Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer and Metastatic Non-Small Cell Lung Cancer Followed by Pembrolizumab
Chang, J. C., Bernicker, E. H., Butler, E. B., Chan, E. Y., Farach, A. M., Gupta, N., Heyne, K., Kopas, L., Niravath, P. A., Singh, M., Sultenfuss, M. A., Teh, B. S. & Zhang, J.
Project: Clinical Trial
-
Contemporary trends in management of uveal melanoma
Chevli, N., Zuhour, R. J., Messer, J. A., Haque, W., Schefler, A. C., Bernicker, E. H., Chevez-Barrios, P., Farach, A. M., Butler, E. B. & Teh, B. S., 2022, In: Journal of Contemporary Brachytherapy. 14, 2, p. 123-129 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Localized prostate cancer: An analysis of the CDC Breast and Prostate Cancer Data Quality and Patterns of Care study (CDC PoC-BP)
Celtik, K., Wallis, C. J. D., Lo, M., Lim, K., Lipscomb, J., Fleming, S., Wu, X. C., Anderson, R. T., Thompson, T. D., Farach, A., Hamilton, A. S., Miles, B. J. & Satkunasivam, R., Jul 2022, In: Journal of the Canadian Urological Association. 16, 7Research output: Contribution to journal › Article › peer-review
Open Access -
Adaptive radiation therapy for intact thymoma: An illustrative report
Chevli, N., Bland, R. E., Farach, A. M., Pino, R., Mathews, T., Okoye, E. I., Blackmon, S., Butler, E. B. & Teh, B. S., May 2021, In: Anticancer Research. 41, 5, p. 2467-2571 105 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma
Chevli, N., Chiang, S., Farach, A. M., Haque, W., Satkunasivam, R., Bernicker, E. H., Pino, R., Butler, E. B. & Teh, B. S., Nov 1 2021, In: Advances in Radiation Oncology. 6, 6, 100719.Research output: Contribution to journal › Article › peer-review
Open Access -
Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
Haque, W., Singh, A., Verma, V., Schwartz, M. R., Chevli, N., Hatch, S., Desai, M., Butler, E. B., Arentz, C., Farach, A. & Teh, B. S., Sep 2021, In: Radiotherapy and Oncology. 162, p. 52-59 8 p.Research output: Contribution to journal › Article › peer-review